CTLA4 has a profound impact on the landscape of tumor-infiltrating lymphocytes with a high prognosis value in clear cell renal cell carcinoma (ccRCC)

[31] Muss HB(2020)Effect of combined immune checkpoint inhibition vs best supportive care alone in patients with advanced colorectal cancer: The Canadian Cancer Trials Group CO.26 Study JAMA Oncol 20 7-undefined

[32] Shachar SS(2020)CTLA-4 correlates with immune and clinical characteristics of glioma Cancer Cell Int 10 29-undefined

[33] Moschos SJ(2009)Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection Nat Immunol 18 2240-undefined

[34] van de Ven K(2011)Indoleamine 2,3-dioxygenase, Tregs and cancer Curr Med Chem 8 242-undefined

[35] Borst J(2017)Immune checkpoint in glioblastoma: promising and challenging Front Pharmacol 112 6140-undefined

[36] Gough SC(2015)Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients ProcNatlAcadSci USA 7 331-undefined

[37] Walker LS(2019)PD1(Hi) CD8(+) T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma J Immunother Cancer 16 599-undefined

[38] Sansom DM(2016)Regulatory circuits of T cell function in cancer Nat Rev Immunol 330 1410-undefined

[39] Peggs KS(2010)Frequent mutation of BAP1 in metastasizing uveal melanomas Science 63 848-undefined

[40] Quezada SA(2013)Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma EurUrol 234 8509-undefined

[31] Muss HB(2020)Effect of combined immune checkpoint inhibition vs best supportive care alone in patients with advanced colorectal cancer: The Canadian Cancer Trials Group CO.26 Study JAMA Oncol 20 7-undefined

[32] Shachar SS(2020)CTLA-4 correlates with immune and clinical characteristics of glioma Cancer Cell Int 10 29-undefined

[33] Moschos SJ(2009)Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection Nat Immunol 18 2240-undefined

[34] van de Ven K(2011)Indoleamine 2,3-dioxygenase, Tregs and cancer Curr Med Chem 8 242-undefined

[35] Borst J(2017)Immune checkpoint in glioblastoma: promising and challenging Front Pharmacol 112 6140-undefined

[36] Gough SC(2015)Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients ProcNatlAcadSci USA 7 331-undefined

[37] Walker LS(2019)PD1(Hi) CD8(+) T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma J Immunother Cancer 16 599-undefined

[38] Sansom DM(2016)Regulatory circuits of T cell function in cancer Nat Rev Immunol 330 1410-undefined

[39] Peggs KS(2010)Frequent mutation of BAP1 in metastasizing uveal melanomas Science 63 848-undefined

[40] Quezada SA(2013)Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma EurUrol 234 8509-undefined